Bluefin Capital Management’s Briacell Therapeutics BCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-117
Closed -$99K 227
2022
Q3
$99K Sell
117
-21
-15% -$17.8K 0.01% 216
2022
Q2
$126K Buy
+138
New +$126K 0.01% 235